BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 26426943)

  • 21. The missing cause approach to unmeasured confounding in pharmacoepidemiology.
    Abrahamowicz M; Bjerre LM; Beauchamp ME; LeLorier J; Burne R
    Stat Med; 2016 Mar; 35(7):1001-16. PubMed ID: 26932124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of categorization method, regression type, and variable distribution on the inflation of Type-I error rate when categorizing a confounding variable.
    Barnwell-Ménard JL; Li Q; Cohen AA
    Stat Med; 2015 Mar; 34(6):936-49. PubMed ID: 25504513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bayesian sensitivity analysis for unmeasured confounding in observational studies.
    McCandless LC; Gustafson P; Levy A
    Stat Med; 2007 May; 26(11):2331-47. PubMed ID: 16998821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fallibility in estimating direct effects.
    Cole SR; Hernán MA
    Int J Epidemiol; 2002 Feb; 31(1):163-5. PubMed ID: 11914314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of natural direct effects when a confounder of the mediator is directly affected by exposure.
    Tchetgen Tchetgen EJ; Vanderweele TJ
    Epidemiology; 2014 Mar; 25(2):282-91. PubMed ID: 24487211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of unmeasured within- and between-cluster confounding on the bias of effect estimatorsof a continuous exposure.
    Li Y; Lee Y; Port FK; Robinson BM
    Stat Methods Med Res; 2020 Aug; 29(8):2119-2139. PubMed ID: 31694489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fixed effects analysis of repeated measures data.
    Gunasekara FI; Richardson K; Carter K; Blakely T
    Int J Epidemiol; 2014 Feb; 43(1):264-9. PubMed ID: 24366487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved estimation of controlled direct effects in the presence of unmeasured confounding of intermediate variables.
    Kaufman S; Kaufman JS; MacLehose RF; Greenland S; Poole C
    Stat Med; 2005 Jun; 24(11):1683-702. PubMed ID: 15742358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conditions for confounding of interactions.
    Liu A; Abrahamowicz M; Siemiatycki J
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25(3):287-96. PubMed ID: 26676843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correcting for Measurement Error in Time-Varying Covariates in Marginal Structural Models.
    Kyle RP; Moodie EE; Klein MB; Abrahamowicz M
    Am J Epidemiol; 2016 Aug; 184(3):249-58. PubMed ID: 27416840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mediational E-values: Approximate Sensitivity Analysis for Unmeasured Mediator-Outcome Confounding.
    Smith LH; VanderWeele TJ
    Epidemiology; 2019 Nov; 30(6):835-837. PubMed ID: 31348008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bias in estimating the causal hazard ratio when using two-stage instrumental variable methods.
    Wan F; Small D; Bekelman JE; Mitra N
    Stat Med; 2015 Jun; 34(14):2235-65. PubMed ID: 25800789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How unmeasured confounding in a competing risks setting can affect treatment effect estimates in observational studies.
    Barrowman MA; Peek N; Lambie M; Martin GP; Sperrin M
    BMC Med Res Methodol; 2019 Jul; 19(1):166. PubMed ID: 31366331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A sensitivity analysis using information about measured confounders yielded improved uncertainty assessments for unmeasured confounding.
    McCandless LC; Gustafson P; Levy AR
    J Clin Epidemiol; 2008 Mar; 61(3):247-55. PubMed ID: 18226747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analytic results on the bias due to nondifferential misclassification of a binary mediator.
    Ogburn EL; VanderWeele TJ
    Am J Epidemiol; 2012 Sep; 176(6):555-61. PubMed ID: 22930481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doubly robust estimators of causal exposure effects with missing data in the outcome, exposure or a confounder.
    Williamson EJ; Forbes A; Wolfe R
    Stat Med; 2012 Dec; 31(30):4382-400. PubMed ID: 23086504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bias formulas for sensitivity analysis for direct and indirect effects.
    VanderWeele TJ
    Epidemiology; 2010 Jul; 21(4):540-51. PubMed ID: 20479643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bayesian modeling of cost-effectiveness studies with unmeasured confounding: a simulation study.
    Stamey JD; Beavers DP; Faries D; Price KL; Seaman JW
    Pharm Stat; 2014; 13(1):94-100. PubMed ID: 24446072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing Omitted Confounder Bias in Multilevel Mediation Models.
    Tofighi D; Kelley K
    Multivariate Behav Res; 2016; 51(1):86-105. PubMed ID: 26881959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A general approach to evaluating the bias of 2-stage instrumental variable estimators.
    Wan F; Small D; Mitra N
    Stat Med; 2018 May; 37(12):1997-2015. PubMed ID: 29572890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.